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Abstract
Background: Use of cholera vaccines in response to epidemics (reactive vaccination) may provide an effective supplement
to traditional control measures. In Haiti, reactive vaccination was considered but, until recently, rejected in part due to
limited global supply of vaccine. Using Bissau City, Guinea-Bissau as a case study, we explore neighborhood-level
transmission dynamics to understand if, with limited vaccine and likely delays, reactive vaccination can significantly change
the course of a cholera epidemic.
Methods and Findings: We fit a spatially explicit meta-population model of cholera transmission within Bissau City to data
from 7,551 suspected cholera cases from a 2008 epidemic. We estimated the effect reactive vaccination campaigns would
have had on the epidemic under different levels of vaccine coverage and campaign start dates. We compared highly
focused and diffuse strategies for distributing vaccine throughout the city. We found wide variation in the efficiency of
cholera transmission both within and between areas of the city. ‘‘Hotspots’’, where transmission was most efficient, appear
to drive the epidemic. In particular one area, Bandim, was a necessary driver of the 2008 epidemic in Bissau City. If vaccine
supply were limited but could have been distributed within the first 80 days of the epidemic, targeting vaccination at
Bandim would have averted the most cases both within this area and throughout the city. Regardless of the distribution
strategy used, timely distribution of vaccine in response to an ongoing cholera epidemic can prevent cases and save lives.
Conclusions: Reactive vaccination can be a useful tool for controlling cholera epidemics, especially in urban areas like Bissau
City. Particular neighborhoods may be responsible for driving a city’s cholera epidemic; timely and targeted reactive
vaccination at such neighborhoods may be the most effective way to prevent cholera cases both within that neighborhood
and throughout the city.
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Introduction
With the introduction of inexpensive, easy to administer, and
effective oral vaccines against cholera, vaccination in response to
an epidemic (reactive vaccination) may be an effective supplement
to conventional control measures. Two safe and internationally
licensed oral cholera vaccines are currently available, Dukoral and
Shanchol. Both protect against clinical cholera two or more years
after vaccination, but neither confers long lasting immunity [1–4].
On an epidemic timescale, these vaccines have efficacies ranging
from 66 to 86% [2,5].
Vaccination against cholera has been used preventatively [3,6–
8], but before 2012, we know of only two instances, in The
Federated States of Micronesia in 2000 and Vietnam in 2008,
where vaccination commenced during an epidemic [4,9]. Vaccine
efficacy estimates ranged from 76 to 80%, however, no analysis on
how vaccination affected the course of the epidemic was reported
for either case [4,9].
New data on vaccine performance and the changing epidemi-
ology of cholera prompted the WHO’s Strategic Advisory Group
to recommend in 2010 that reactive vaccination be considered in
specific areas [10]. In order to facilitate rapid procurement and
deployment of an oral cholera vaccine, some have proposed the
creation of a revolving global stockpile [11,12]. While discussions
of the global stockpile proceed, countries that use reactive
vaccination must contend with a limited supply that may arrive
after a significant delay.
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best be distributed in a reactive campaign. The effectiveness of a
campaign and optimal allocation strategy will depend upon local
cholera transmission dynamics, vaccine supply, and logistical
delays [12,13]. Human movement, water and sewerage infra-
structure, and natural waterways facilitate cholera transmission
across a city. Within neighborhoods, there can be marked
variation in the efficiency of transmission.
One country that may benefit from reactive vaccination is
Guinea-Bissau, where outbreaks have occurred every three to four
years since 1994. Sector Auto ´nomo de Bissau (SAB), or Bissau
City, the capital, consistently reports the most cholera cases within
the country (unpublished data, Guinea-Bissau Ministry of Health).
In 2008, 67% of reported cases occurred in SAB while only 25%
of the national population live within its boundaries [14]. Reactive
vaccination in SAB may be possible in future epidemics given the
concentration of cases within the city and the Ministry of Health’s
experience with vaccination campaigns.
Here, we explore the possible effectiveness of different reactive
vaccination strategies using SAB as a case study. We fit a
neighborhood-based meta-population model to the 2008 cholera
epidemic. Using this model, we characterize the spatio-temporal
dynamics of cholera transmission within the city and estimate the
impact that different reactive vaccination strategies could have had
on the course of the epidemic.
Methods
Data Sources
During the 2008 epidemic, the Guinea-Bissau Ministry of
Health, the WHO, and Me `decins Sans Frontie `res implemented a
clinic-based cholera surveillance system, which has been described
previously [15]. In brief, upon arrival at either the cholera
treatment center in the Hospital National Simao Mendes or one of
five cholera treatment units (Figure 1C and 1D), health care
providers entered patients into a surveillance registry. A patient’s
age, sex, area of residence, treatment facility, date of presentation,
and clinical diagnosis were recorded.
Modified WHO cholera case definitions were used [15]. A
suspected case was any person suffering from acute watery
diarrhea, and a confirmed case was a suspected case with a
positive stool sample containing Vibrio cholerae O1 or O139. We
included all suspected and confirmed cases with complete
information on their presentation date and home sanitary area
in this analysis. The population for each sanitary area within the
city was extrapolated from 1991 census data using a constant
linear growth rate estimated by the Direcc ¸a ˜o-Geral Sau ´de. To
estimate the population density in each sanitary area we traced the
residential areas using Google Earth (v6.0.3.2197), then divided
each sanitary area’s population by its estimated residential area.
Model of Cholera Spread in SAB
We fit a discrete-time Susceptible-Infectious-Recovered meta-
population model to the confirmed and suspected cases reported
during the 2008 epidemic with each of 14 sanitary areas in SAB
treated as a distinct population. We assume the epidemic follows a
first-order Markov process with a fixed generation time of five
days. At each time step, the incidence in each area follows a
Poisson distribution with a mean determined by the number
infected in the last time step in all areas and the proportion of the
area’s population remaining susceptible. After infection, individ-
uals were assumed to remain immune for the duration of the
epidemic (See Text S1 for model details).
We considered models of cholera transmission with and without
seasonality assuming (A) equal transmission coefficients between
and within all areas of SAB; (B) different transmission coefficients
within each area and equal transmission coefficients between all
areas; (C) different transmission coefficients within each area and
unique symmetric transmission coefficients between each pair of
areas; and, (D) different transmission coefficients within each area
and unique asymmetric transmission coefficients between each
pair of areas in the city. We chose the best model based on
Deviance Information Criteria (Text S1). To assess fit we
simulated 300,000 epidemics predicting five, fifteen, and fifty
days ahead drawing new parameters from the posterior distribu-
tion every 1000 simulations.
Posterior distributions were approximated using Markov Chain
Monte Carlo methods using JAGS 3.1.0 and R 2.14.0 with non-
informative priors [16,17]. We ran 3 chains of 400,000 iterations
with a burn in of 50,000, and assessed convergence using the
potential scale reduction factor and through visual inspection [18].
Vaccination
We assume every vaccinated individual receives two doses in a
vaccine campaign over a 20 day period and that 75% are fully
protected (VEs~0:75 [19]) [3,5,6,20]. In our model vaccinees get
no protection until 10 days after the second dose [21,22]. Hence,
75% of the susceptible vaccinees are considered immune starting
30 days after their first dose, with no protection before (Table 1).
We considered campaigns with 50,000, 75,000, or 100,000
doses (i.e. 25,000, 37,500, and 50,000 individuals vaccinated) and
targeted vaccination at one, two, three, or all (14) areas (Table 3).
When the proposed number of vaccinees in a specific area
exceeded the population size, we distributed vaccine to the other
vaccination areas or, in the campaigns with one vaccination area,
we dispersed the vaccine throughout the city with each person
having equal probability of getting vaccinated. We varied the
starting time of the vaccination campaign between 20 and 120
days after the first case was detected.
We considered targeted and diffuse (city-wide) campaigns. In
diffuse campaigns, vaccine was distributed throughout all areas of
SAB. In targeted campaigns, we considered three different
Author Summary
Cholera remains a major public health threat, causing 3–5
million cases and 100,000–120,000 deaths each year. In
2010, data on vaccine performance and the changing
epidemiology of cholera prompted the WHO’s Strategic
Advisory Group to recommend that reactive vaccination
be considered in specific areas. We built a spatially explicit
stochastic model of cholera transmission and fit it to data
from a 2008 epidemic in Bissau City, Guinea Bissau. Using
this model we examined the potential effectiveness of
reactive vaccination for controlling cholera transmission in
Bissau City, comparing strategies for distributing limited
vaccine. In simulations, early targeting of a single
transmission ‘‘hotspot’’, Bandim, was the most effective
strategy, and led to the greatest reduction in cases both
within Bandim and in areas where no vaccine was
distributed. This finding has implications for cholera
control in urban settings in general: public health officials
will often know which areas of a city were hotspots of
cholera transmission in the past or where conditions
promote efficient transmission. When there is limited
vaccine, our work suggests that targeting reactive vacci-
nation at these areas will lead to the greatest reduction in
cases both in these areas and elsewhere in the city.
Cholera Transmission in Bissau City, Guinea Bissau
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strategy, we selected the areas with the largest population. In the
connectivity-based strategy, we vaccinated in areas estimated to be
most ‘‘connected’’ to other areas. In the attack rate-based strategy,
we chose the areas with the highest attack rate in the 2008
epidemic. We allocated vaccine proportional to population size in
all simulations.
Simulation Studies
For each vaccination scenario we ran 5,000 simulations
calculating the difference between the final epidemic size with
and without vaccination. Epidemics were assumed to follow the
observed 2008 epidemic course until 30 days after the first dose. In
each simulation we drew new parameters from the joint posterior
distribution. As a sensitivity analysis, we ran simulations with
Figure 1. The 2008 cholera epidemic in SAB. Panel A (solid line) shows suspected and confirmed cholera cases reporting to cholera treatment
centers/units (shown as circles and triangles) throughout all areas of SAB aggregated in 5-day intervals. The dashed line below (B) shows 5-day
aggregated cases from Bandim, the area with the highest attack rate (40.6 per 1000). Panel C illustrates the day of the first reported case for each area.
Attack rates (per 1000) for each area are shown in D.
doi:10.1371/journal.pntd.0001901.g001
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85%). Additional simulation study details are available in Text S1.
Ethics Statement
Original data collection was approved by the Me `decins Sans
Frontie `res ERB and the National Ethical Review Board of
Guinea-Bissau [15]. The analyses presented in this article were
conducted on de-identified data and deemed to be non-human
subject research by the Johns Hopkins Bloomberg School of Public
Health IRB.
Results
The 2008 Cholera Epidemic
The first case in SAB was reported on June 5, 2008 in Bairro-
Militar, the most populated area of the city (Figures 1A, 1B), one
month after the first reported case in Guinea-Bissau. Within three
weeks, all 14 areas had reported cases (Figure 1C). The Ministry of
Health officially declared an epidemic one month after the first
case report from SAB. The National Laboratory of Microbiology
and the Pasteur Laboratory in Dakar, Senegal identified all
positive specimens analyzed as Vibrio cholerae O1 El Tor Ogawa.
Nationally, 14,226 suspected cases and 228 deaths were
reported with 67% (9,393) of cases and 32% (73) of deaths
reported in SAB. The last case in the country was reported in SAB
on January 11, 2009. Individual-level data in SAB was collected
between June 5, 2008 and October 28, 2008, over which time
8,024 (85%) suspected and confirmed cases were reported. These
analyses focus on 7,551 suspected and confirmed cases with
complete information on date of presentation, home area, and
clinical diagnosis (Figure S1).
In SAB, weekly incidence ranged from 14 to 755. Within-area
attack rates ranged from 9.1 to 40.6 per 1,000 (Table 2, Figure 1D),
with Bandim having both the most cases (1,816) and the highest
attack rate.
Spatial Spread of Cholera in SAB
The final model fit both the overall and area-specific epidemic
curves well, even when predicting as far as 50 days (i.e. 10 time
steps) ahead (Figures 2A,2B). To understand how transmission
varied through time, we calculated the odds that an incident case
was caused locally (i.e. attributable to transmission between people
in the same area) for each area throughout the course of the
epidemic (Figure 3). Only Bandim, Plaque, and Santa-Luzia have
an odds consistently greater than 1, suggesting internally driven
epidemics in these areas.
Table 1. Overview of assumptions related to vaccination and
immunity.
Vaccine efficacy 75%
Doses per individual 2
Immunity before second vaccine dose None
Duration of vaccination campaign 20 days
Time from second vaccine dose to complete
protection
10 days
Proportion immune after natural infection 100%
Length of immunity from natural infection or
successful vaccination
Duration of the epidemic
Main assumptions used in primary analysis related to vaccination and immunity.
Additional details are provided in the methods section and Text S1.
doi:10.1371/journal.pntd.0001901.t001
Table 2. Overview of sanitary areas in SAB.
Sanitary Area Population
Suspected and
Confirmed Cases
Attack Rate
(per 1,000)
Barrio-Militar 65,274 944 14.5
Bandim 44,718 1,816 40.6
Cuntum 45,482 890 19.6
Missira 38,838 532 13.7
Antula 30,778 662 21.5
Quelele 28,898 493 17.1
Plaque 27,633 396 14.3
Luanda 25,236 229 9.1
Sintra Nema 21,451 355 16.5
Belem 17,263 322 18.7
Santa-Luzia 17,204 261 15.2
CIM 14,985 161 10.7
Pefine 14,808 324 21.9
Ajuda 10,429 164 15.7
All SAB 402,997 7,549 18.7
Estimated 2008 population for each sanitary area projected from 1991 census
data (second column). Suspected and confirmed cases with complete location
and time data and attack rate during 2008 cholera epidemic (third and fourth
columns).
doi:10.1371/journal.pntd.0001901.t002
Table 3. Vaccination scenarios.
Vaccination Strategy
Areas Vaccinated Population Connectivity Attack Rate Vaccination Start Day Doses
1 Area Bairro Militar (1.00) Missira (1.00) Bandim (1.00) 20–120 50,000–100,000
2 Areas Bairro Militar (0.59) Missira (0.69) Bandim (0.75) 20–120 50,000–100,000
Cuntum (0.41) Santa-Luzia (0.31) Pefine (0.25)
3 Areas Bairro Militar (0.42) Missira (0.46) Bandim (0.50) 20–120 50,000–100,000
Cuntum (0.29) Santa-Luzia (0.21) Pefine (0.16)
Bandim (0.29) Plaque (0.33) Antula (0.34)
For each scenario we chose the top 1, 2, and 3 areas that met the vaccination strategy criteria. The number of vaccinees in each area were weighted (shown in
parenthesis) to ensure that vaccines were allocated proportional to population size in all simulations.
doi:10.1371/journal.pntd.0001901.t003
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the expected number of cases caused within a given area by one
infected individual, within the same area, at the beginning of the
epidemic. Only areas with Rintw1 c a ns u s t a i na ne p i d e m i ca b s e n t
infections introduced from other areas. The strength of internal
epidemics varied with estimates of Rint ranging from 0.01 (95%
Credible Interval (CI) 0.00–0.07) in Ajuda to 1.17 (95% CI 0.99–1.33)
in Bandim (Figure 4). We found no significant correlation between
Rint and either estimated population size or population density.
Bandim is the only area where we estimate Rintw1, and it
appears to have played a necessary role in driving the epidemic.
With Bandim removed, simulated introductions of cases fail to
cause epidemics. In contrast, city-wide epidemics occur with
removal of any other single area.
In simulated epidemics based upon our best-fit model, we find
that, on average, at least 10% of cases in each area are caused by
cases in other areas (Figure 2C, Text S1). External transmission
coefficients represent epidemic connectivity between areas, and
Figure 2. Cholera transmission model overview. 10-step ahead (50 day) predictions for all of SAB (A) and Bandim (B) with 95% predictive
interval bands. The arrows in Panel C illustrate the proportion of cases estimated to be caused in each area (head of arrow) by another (tail end of
arrow). Panel D illustrates the mean effective internal reproductive number (Rint) for each area (colors), and the proportion of each areas epidemic
estimated to be caused by Bandim (arrows). Arrow size and transparency are scaled by the magnitude with a minimum of 10% shown.
doi:10.1371/journal.pntd.0001901.g002
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(Text S1). Based on simulations, we estimate that Bandim
contributed over 10% of the cases to over half (7/13) of the other
areas (Figure 2D), highlighting the crucial role it played in the
epidemic.
The sum of the external transmission coefficients for any area
provides an estimate of the effective external basic reproductive
number (Rext). This number is the estimated number of cases a
single infectious case in that area would cause in all other areas of
SAB given the pre-epidemic level of population immunity.
Estimates of Rext ranged from 0.37 (95% CI 0.16–0.71) in Belem
to 7.32 (95% CI 6.29–8.37) in Missira (Figure 4).
Reactive Vaccination Simulations
Vaccination in the area(s) with the highest attack rate leads to
larger reduction in cases than all other targeted and city-wide
campaigns at all starting times. Targeting vaccination at Bandim
only, the area with the highest attack rate, within the first 80 days
of the epidemic averts more cases than other strategies regardless
of vaccine quantity (Figure 5). Targeted vaccination in Bandim
Figure 3. Odds of internally caused case over time by area. Odds of a case being caused internally (i.e. as a result of other cases in that area)
vs. externally for all areas throughout the epidemic, sorted by attack rate (top to bottom). Red represents those values in support of an internally
driven epidemic and blue represents those supporting an externally driven epidemic. The observed epidemic curve is shown above in grey for
reference.
doi:10.1371/journal.pntd.0001901.g003
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epidemic by 41% (95% Predictive Interval (PI) 0.21–0.69), 56%
(95% PI 0.30–0.85), and 67% (95% PI 0.40–0.89) with 25,000,
37,500, and 50,000 vaccinees, respectively. In comparison, a city-
wide campaign starting on the same day is expected to reduce the
epidemic size by 21% (95% PI 0.07–0.34), 30% (95% PI 0.17–
0.44), and 40% (95% PI 0.27–0.55) for 25,000, 37,500, and 50,000
vaccinees (Tables 4,S1,S2).
Wefound wide variability inthe outcomes using different targeting
strategies, with the differences diminishing as vaccination is delayed
(Figure 5). Under the population-based strategy, only a targeted
campaign in the three most populated areas averts more cases than a
city-wide campaign (Figure5, Table4). Targeting the areas estimated
to be most ‘‘connected’’ to others averts fewer cases than city-wide
campaigns regardless of vaccination starting time and doses.
Starting day has a profound impact on the effect of all
vaccination campaigns: the sooner vaccination begins, the more
cases are averted. With 37,500 vaccinees, each day delay in
vaccination results in an average of 39.5 (95% CI 37.7–44.2) fewer
cases averted when targeting based on attack rate. Increasing the
size of a vaccination campaign early on in the epidemic can
significantly improve case prevention, however, the marginal
benefit of additional vaccine diminishes as vaccination is delayed.
On average, each additional person vaccinated as part of a
targeted campaign in Bandim starting on day 20 averts 7.5 cases
compared to 1.7 cases averted per vaccinee in campaigns starting
two months later.
In simulations, early targeted vaccination leads to fewer cases both
withinthe targeted area andthroughoutthecitywhencomparedtodiffuse
campaigns. When starting vaccination on day 20 (Figure 6A),
targeting Bandim averts more cases both in Bandim (1,173) and in all
the other areas combined (2,265) when compared to a city-wide
campaign (341averted in Bandimand 1,741 in allother areas).Asthe
vaccination campaign is delayed, these differences shrink (Figure 6).
Figure 4. Mean Rint, Rext and 95% credible intervals. Sorted from top to bottom by Rint.
doi:10.1371/journal.pntd.0001901.g004
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proportion of cases averted by vaccination start time for (A) attack rate-based, (B) population-based, and (C) connectivity-based targeting strategies.
The colored lines represent the different number of areas vaccinated. Estimates made from simulations starting at the time of vaccination with 37,500
individuals vaccinated (75,000 doses). Purple lines (14 vaccination areas) are the same in each panel.
doi:10.1371/journal.pntd.0001901.g005
Table 4. Vaccination scenario results summary.
Vaccination Campaign Start Time
Distribution
Strategy
# Areas
Vacc. Day 20 Day 60 Day 80 Day 100
Cases % Cases % Cases % Cases %
Attack Rate 1 area 4228 0.56 2342 0.30 970 0.12 345 0.04
2263,6424 0.30,0.85 1195,3392 0.16,0.41 197,1732 0.03,0.21 2186,887 20.02,0.10
2 areas 3954 0.53 2266 0.29 986 0.13 379 0.05
2142,6214 0.29,0.82 1156,3258 0.16,0.40 238,1732 0.03,0.21 2146,928 20.02,0.11
3 areas 3422 0.46 2025 0.26 975 0.12 433 0.05
1903,5174 0.27,0.69 1021,2993 0.14,0.36 222,1708 0.03,0.20 271,964 20.01,0.11
Population 1 area 1804 0.24 1272 0.16 777 0.10 359 0.04
558,3250 0.08,0.41 254,2276 0.03,0.28 27,1565 0,0.19 2166,897 20.02,0.10
2 areas 1974 0.26 1405 0.18 859 0.11 396 0.05
824,3355 0.12,0.42 432,2361 0.06,0.29 102,1633 0.01,0.19 2120,936 20.02,0.11
3 areas 3019 0.40 1928 0.25 996 0.13 414 0.05
1727,4534 0.24,0.59 976,2902 0.13,0.35 269,1739 0.04,0.21 292,941 20.01,0.11
Connectivity 1 area 666 0.09 476 0.06 322 0.04 181 0.02
2363,1742 20.05,0.22 2404,1372 20.05,0.17 2436,1102 20.06,0.13 2349,716 20.04,0.08
2 areas 1258 0.17 827 0.11 566 0.07 326 0.04
154,2375 0.02,0.3 262,1741 20.01,0.21 2129,1322 20.02,0.16 2198,863 20.03,0.10
3 areas 1792 0.24 1255 0.16 828 0.10 427 0.05
603,3032 0.09,0.39 339,2243 0.05,0.27 104,1574 0.01,0.19 274,967 20.01,0.11
Diffuse/City-Wide 14 areas 2271 0.30 1521 0.20 872 0.11 421 0.05
1170,3450 0.17,0.44 658,2464 0.09,0.30 150,1623 0.02,0.19 271,947 20.01,0.11
Median count and percent of cases averted by targeting strategy (indicated by left-most column) and vaccination start day (epidemic day) for 75,000 doses (37,500
vaccinees). Values were estimated from simulations starting from the first time period where any vaccinee gained protective immunity. 95% predictive intervals (PIs) are
shown below each median value. Differences were calculated from time that the first vaccinated individuals are protected.
doi:10.1371/journal.pntd.0001901.t004
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Using a simple spatially explicit model of cholera transmission,
we captured the essential dynamics of the 2008 cholera epidemic
in SAB, Guinea-Bissau. This model suggests that there was
significant transmission between areas in SAB and that one area,
Bandim, drove the epidemic. Our simulations show that early
distribution of vaccine is the most important determinant of the
number of cases prevented. For example, vaccinating 25,000
individuals in Bandim on epidemic day 20 would have averted
more cases (3,109, 95% PI 1,475–5,198) than vaccinating 50,000
in the same area just 40 days later (2,732, 95% PI 1,630–3,738).
Our simulations suggest that an early vaccination campaign
targeted at Bandim alone would have outperformed distributing
the same vaccine quantity throughout the city. Not only are more
cases prevented overall, but more are prevented in areas outside of
Bandim.
Our results suggest that rapid small-scale vaccination may be
more effective than a delayed larger-scale vaccination campaign.
For example, on average, each day delay results in an additional
39.5 cases when targeting 37,500 people in the areas with the
highest attack rate. Applying the average case fatality ratio from
the 2008 epidemic (1.58 per 100 cases [15]) we estimate that each
week delay in vaccination would have resulted in an average of 4.4
cholera-related deaths.
Transmission hotspots for other infectious diseases have been
exploited to devise novel prevention and control approaches
[23,24]. For example, targeted interventions in hotspots may be
Figure 6. Comparison of cumulative cases within (red) and outside (blue) Bandim under targeted and diffuse vaccination. Dashed
lines represent the median number of cases in simulations with vaccination, and the solid lines represent the median number of cases in uncontrolled
epidemic simulations (no vaccination). Each row (panels A–C) represents simulations with vaccination started at the epidemic day denoted on the
right hand side (e.g. Day 20). Simulations were started from the reported number of cases in the first 5 days of the epidemic.
doi:10.1371/journal.pntd.0001901.g006
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cholera hotspots can serve as targets for both reactive and
preventative interventions. Identification of hotspots during an
epidemic may be challenging. In the case of SAB, Bandim is an
area which has had high attack rates in previous epidemics and
few improvements in water and sanitation infrastructure. Such
historical information may be useful in targeting vaccination;
however, more research on combining historical and real-time
surveillance data is needed.
In our model, vaccination campaigns lasted 20 days, but in
reality the duration will vary by the number of vaccinees targeted
and the vaccine used. If Shanchol were used with the
recommended inter-dose period of 14 days, the campaign would
likely exceed 20 days. While this suggests that our results
underestimate the speed by which Shanchol vaccination would
occur, these differences would be offset by partial immunity
conferred before a second dose [22].
As the time to distribute vaccine doses increases, we expect to
avert fewer cases. However, there is some evidence that a single
dose of oral cholera vaccine may be sufficient for reactive
vaccination [22,25]. If one dose is sufficient to elicit a strong
protective response for the time-scale of an epidemic, more people
could be vaccinated quickly.
Cholera’s generation time is not well characterized and varies
widely with the concentration of bacteria in the environment, its
survival rate, and the route of transmission [26–28]. We ran analyses
with alternate generation times of 3, 7, and 10 days and got the same
qualitative results (Figures S3, S4, S5, S6, S7, S8 and Tables S3, S4,
S5). We also found that varying the vaccine efficacy to 65% and 85%
changed the number of cases averted, but preserved the relative
performance of each strategy over time (Figure S2 and Tables S7,S6).
There are a number of limitations to this work. We focus on a
single epidemic in Guinea-Bissau. A longer time series would
provide insight into variability in transmission across epidemics.
The data came from an intensified surveillance effort from both
Me `decins Sans Frontie `res and the Guinea-Bissau Ministry of
Health, however suspected cases that presented after October 28,
2008 were only captured by the national surveillance system
without details on timing and home sanitary area.
There are several possible alternative explanations for the elevated
attack rate in Bandim. The cholera case definition used is not 100%
specific,and somecholera cases maybe falsepositives.Peoplemaybe
more likely to seek care if their neighbors do, hence clinic visits may
cluster even if cholera does not. In addition, Bandim has been the
location to several surveillance programs and public health interven-
tions through the Bandim Health Project [29], perhaps leading to
increased awareness. However, if these phenomena were consistent
throughout the epidemic they would not lead to elevated estimates of
the local transmission rate under our algorithm.
We found that how rapidly vaccine can be distributed during a
cholera epidemic is the most important determinant of the
effectiveness of a reactive vaccination program; and that a single
area of SAB was an essential driver of the epidemic. Hence, early
targeting of this area would have been the most effective way to
reactively distribute vaccine. These results may apply to urban
cholera epidemics more generally. It seems reasonable that cholera
epidemics in other urban settings, particularly in Africa, may be
disproportionally driven by specific parts of the city. If these
hotspots can be identified, targeted reactive vaccination may be an
effective way to prevent cases both within that area and
throughout the city, especially when vaccine supply is limited.
Regardless of the distribution strategy used, timely distribution of
vaccine in response to an ongoing cholera epidemic can prevent
cases and save lives.
Supporting Information
Figure S1 5-day aggregated case counts for all sanitary
areas during the 2008 epidemic. Data collected from cholera
treatment center and cholera treatment units throughout the city
from June 5, 2008 to October 28, 2008.
(TIF)
Figure S2 Vaccine efficacy sensitivity analysis.Compar-
ison of proportion of epidemic averted with different 65%, 75% (as
in main analysis), and 85% vaccine efficacy over different
vaccination starting times. All scenarios shown use attack rate
based targeting.
(TIF)
Figure S3 Comparison of transmission parameters
with different generation times. Posterior means and
standard deviation for transmission coefficients, (log(b)’s on
diagonals and log(a)’s on off-diagonals) with 3, 5, and 7 day
generation times.
(TIF)
Figure S4 Comparison of internal and external effective
reproductive numbers for different generation time
aggregations.
(TIF)
Figure S5 Proportion of cases caused in each area by
others from 3, 5, 7, and 10-day generation time models.
The sum of each row is equal to one, representing 100% of the
area’s epidemic.
(TIF)
Figure S6 Vaccination simulation results with 3-day
generation time, 75% vaccine efficacy, and 75,000 doses.
(TIF)
Figure S7 Vaccination simulation results with 7-day
generation time, 75% vaccine efficacy, and 75,000 doses.
(TIF)
Figure S8 Vaccination simulation results with 10-day
generation time, 75% vaccine efficacy, and 75,000 doses.
(TIF)
Table S1 Vaccination simulation results with 50,000
doses and 75% vaccine efficacy. Proportion and number of
cases averted in 5,000 simulations under different vaccination
strategies (Median and 95% Predictive Interval).
(DOCX)
Table S2 Vaccination simulation results with 100,000
doses and 75% vaccine efficacy. Proportion and number of
cases averted in 5,000 simulations under different vaccination
strategies (Median and 95% Predictive Interval).
(DOCX)
Table S3 Vaccination simulation results from 3-day
generation time model, 75,000 doses. Proportion and
number of cases averted in 5,000 simulations under different
vaccination strategies (Median and 95% Predictive Interval).
(DOCX)
Table S4 Vaccination simulation results from 7-day
generation time model, 75,000 doses. Proportion and
number of cases averted in 5,000 simulations under different
vaccination strategies (Median and 95% Predictive Interval).
(DOCX)
Table S5 Vaccination simulation results from 10-day
generation time model. Proportion and number of cases
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(Median and 95% Predictive Interval).
(DOCX)
Table S6 Vaccination simulation results with 75,000
doses and 65% vaccine efficacy. Proportion and number of
cases averted in 5,000 simulations under different vaccination
strategies (Median and 95% Predictive Interval).
(DOCX)
Table S7 Vaccination simulation results with 75,000
doses and 85% vaccine efficacy. Proportion and number of
cases averted in 5,000 simulations under different vaccination
strategies (Median and 95% Predictive Interval).
(DOCX)
Text S1 Details on final model, model selection, and
simulations.
(PDF)
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